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A B S T R A C T
Status epilepticus is a life threatening condition with a high mortality rate in spite of aggressive
treatment. There is little consensus on third and fourth line approaches in refractory cases. While
electroconvulsive therapy (ECT) has been employed successfully as a treatment for refractory epilepsy
and status epilepticus (SE) after exhausting conventional therapy, its use for pediatric patients is limited.
We describe a 7-year-old pediatric case in which ECT was used successfully to treat medically refractory
nonconvulsive status epilepticus (NCSE) without complete withdrawal of antiepileptic drugs (AED).
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Status epilepticus (SE) affects 120,000–200,000 Americans per
year, of which 25–50%may be considered non-convulsive SE.1 SE is
life-threatening condition, with a mortality rate of 1.9 to as high as
40%, depending on the population studied.2 Due to its high
mortality and morbidity, multiple approaches have been sug-
gested to treat SE, including general anesthesia. However, in spite
of putting patients into comatose state under general anesthesia or
barbiturates, mortality rate is still high, about 20%.3 Although
deﬁnitions of refractory SE vary, it is thought to occur between 10–
70% of cases.4 Electroconvulsive therapy (ECT) has been employed
successfully as a treatment for refractory epilepsy and SE after
exhausting conventional therapy.4–6 However, ECT use in pediatric
patients is limited, even in psychiatric illness.7 In a limited
previous case series of ECT treatment in pediatric patients for
refractory epilepsy, AED were halt during the ECT course.6 We
describe a pediatric case in which ECT was used successfully to
treat medically refractory nonconvulsive status epilepticus (NCSE)
while the AED were continued.Abbreviations: VPA, Valproate; LEV, Levetiracetam; CLB, Clobazam; LOR, Loarze-
pam; PB, Phenobarbital; MDZ, Midazolam; FEN, Fentanyl; TPM, Topiramate; PEN,
Pentobarbital; KET, Ketamine.
* Corresponding author at: 101 Canal Street, APT 204, Boston, MA 02114, United
States. Tel.: +1 336 406 3200, +1 336 806 4243; fax: +1 336 716 2810.
E-mail address: hshin7507@gmail.com (H.W. Shin).
1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.01.0092. Case report
2.1. History
A 7-year-old female with cerebral palsy, extensive bilateral
polymicrogyria throughout both hemispheres predominately
involving the medial parietal lobes and lesser degree to bilateral
frontal lobes and right insula/superior temporal lobe, develop-
mental delay, and intractable epilepsy with previous treatment
with ketogenic diet and phenobarbital was admitted to our
Epilepsy Monitoring Unit (EMU). On the day of admission to EMU,
she developed NCSE with generalized spike and waves 1–2 Hz
while on valproate, levetiracetam and clobazam (Fig. 1A). Multiple
intravenous loads of benzodiazepam, levetiracetam, phenobarbital
did not halt her NCSE.
2.2. Medical treatment
She was transferred to the pediatric intensive care unit for
further management of her NCSE on hospital day 1. Burst
suppression was achieved on hospital day 2 with a combination
of concomitant intravenous anesthetics, includingwithmidazolam
drip, pentobarbital drip, ketamine drip, topiramate load, and high
dose steroid as well as continuation of AEDs on admission. She
remained in burst suppression for the next 12 days. Electrographic
seizures recurred when attempting to wean her from high dose
anesthetic therapy.vier Ltd. All rights reserved.
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Fig. 1. Electroencephalogram evolution: NCSE shortly after the admission in A; after the ﬁnal ECT stimulations in B; Post-hospitalization outpatient EEG (11 weeks after the
discharge from hospital) in C.
(A) Generalized spike and wave lasting up to several hours on day of admission to EMU while on valproate, levetiracetam, and clonazepam; 30 mV/mm, 70 Hz.
(B) Remission of NCSE 14 h after the fourth course of ECT with slow background and BIPLEDs persisting a couple weeks after ﬁnal ECT; 7 mV/mm, 70 Hz.
(C) EEG 11 weeks after hospital discharge showing rare left frontotemporal spikes; 10 mV/mm, 70 Hz.
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After unsuccessful attempts to wean from drug induced coma
due to return of NCSE, ECT treatment was initiated on hospital day
14with parental consent. The pediatric anesthesia teampretreated
with atropine and rocuronium and vitals remained stablethroughout the ECT course. Bitemporal electrode placement was
selected to produce the most generalized seizure, given the lack of
a clear seizure focus. A single frontal-mastoid EEG recording
montage was employed using the MECTA ECT device, as the ECT
stimulus would be damaging to the ampliﬁers used for full EEG
monitoring. She received two consecutive ECT sessions with three
Table 1
Clinical and electroencaphalograhic summary of hospital course with ECT stimulus.
Hospital day Clinical feature Medications EEG ﬁndings ECT stimulus (pulse width/frequency/duration) After ECTa treatment
EEG change
in 24h
Clinical
outcome
0 decreased response VPA, LEV, CLB, LOR NCSE with generalized spike and
waves 1–2Hz
1 comatose VPA, LEV, CLB, LOR,
PB, MDZ, FEN, Steroid
NCSE
2–13 comatose VPA, LEV, CLB, PB, MDZ,
steroid, TPM, PEN, KET
burst suppression
14 comatose VPA, LEV, CLB, MDZ,
steroid, TPM, PEN, KET
NCSE with generalized spike and
waves 1–2Hz
1/60/3
1/60/6
2/60/3
none Comatose
15 comatose VPA, LEV, CLB, MDZ
reversed with ﬂumazenil
prior to ECT, Steroid, PB, TPM
NCSE 2/60/3
0.37/120/8
1/60/6
cessation of NCSE
within 6h after
ECT
Comatose
17–20 comatose VPA, LEV, CLB, MDZ, steroid,
TPM, PB
beta frequency NCSE
21 comatose VPA, LEV, CLB, MDZ, steroid,
TPM, PB
beta frequency NCSE 2/60/3
0.37/120/8
2/60/3
no change comatose
22 comatose VPA, LEV, CLB, MDZ, steroid,
TPM, PB
beta frequency NCSE 1/60/6
1/60/6
2/60/43
cessation of
NCSE within
14h with BIPLEDs
comatose
40 resolution of comatose
state but severe stupur
VPA, LEV, CLB, TPM decreased amount of BIPLEDs,
generalized slowing up to 3Hz
48–58 moderate encephalopathy
but more alert and mildly
interactive
VPA, LEV, CLB, TPM resolution of BIPLEDs, frequent
generalized 2Hz spike and wave
with Left hemispheric predominance,
generalized background slowing
with 2–4Hz
11 weeks after
discharge from
hospital
close back to her baseline
of her mental status but
generalized motor weakness
VPA, LEV, CLB, TPM background slowing up to 5–6Hz
with superimposed beta activity
and rare left frontotemporal spike
and wave
a ECT stimulus (800 milliamps constant current) pulse width (ms)/frequency (HZ)/duration (s)
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twomore sessions oneweek later (hospital day 21 and 22) (Table 1).
A number of different stimulus parameters were employed as
described in Table 1. Pentobarbital and ketamine dripswereweaned
offduringherECTsessions.Midazolamwas reversedwithﬂumazenil
prior to each session in order to lower seizure threshold for ECT
induced generalized seizure. However, valproic acid, topiramate,
levetiracetam, and clonazepamwere continued during ECT sessions.
2.4. Response to ECT
NCSE was terminated initially after two sessions on successive
days with three stimulations per day. Two days after initial
cessation of her seizure, NCSE with beta frequency returned and
continued for ﬁve days despite multiple medical interventions.
Based upon the initial promising results with ECT, she received an
additional successful six stimulations one week following the ﬁrst
series (Table 1).
Fourteen hours after her ﬁnal series of ECT treatments, her NCSE
was stopped with generalized slowing and BIPLEDs in EEG (Fig. 1B
and Table 1). Her AEDs were successfully weaned to valproate,
topiramate, levetiracetam, and clobazam. Over the three weeks
following her last ECT treatment, multiple routine inpatient EEGs
showed complete resolution of BIPLEDs but intermittent infre-
quent 2-4 Hz generalized spike and wave. Subsequently, her
mental status also improved. Shewas awake and interactive. Three
weeks after ﬁnal ECT and weaning of medicine, she was able to go
home with infrequent absence seizures and moderate encepha-
lopathy.
2.5. Post hospital outcome
Eleven weeks after discharge from hospital, her outpatient EEG
improved with rare left frontotemporal spikes without subclinical
seizure (Fig. 1C). Her mental status improved further. Unfortu-
nately, she passed away suddenly several weeks later likely from
sudden unexpected death in epilepsy (SUDEP).
3. Discussion
Electroconvulsive therapy (ECT) has been employed successfully
as a treatment for refractory epilepsy and SE after exhausting
conventional therapy.4–6 However, the exact mechanism for ECT to
anticonvulsive effect is not clear. Multiple theories have been
suggested. The most commonly accepted thought is its GABAnergic
effect. Electroconvulsive shock in animals is associated with the
engagement of strong anticonvulsant mechanisms, probably medi-
ated by GABA. These anticonvulsant effects build and accumulate
with repeated induced-seizures given over several days, and the
effect persists for days up to a few weeks after ECT is over.8,9
The seizure threshold, as measured in the amount of electrical
charge that is required to produce a seizure, increases over the
course of ECT, as the anti-convulsant mechanisms takes hold. In
neurologically intact depressed adults, it is clear that the degree of
EEG-seizure generalization is dependent upon location of the
stimulus electrodes, as well as the electrical dose.10 Further, the
efﬁciency at which a given amount of electrical charge will induce
a seizure varies as a function of the speciﬁc electrical parameters of
current, pulse width, frequency of stimuli, and stimulus train
duration. For these reasons, stimulus parameters may vary over a
course of ECT.
Despite the effectiveness of ECT in SE, very few cases have been
reported in the literature. Griesemer reported one pediatric case
series on the use of ECT to treat two children with refractoryepilepsy. The ﬁrst patient was a 13-year-old boy with microgyria
and intractable epilepsy despite multiple AEDs with frequent
seizures. He received four sessions of ECT treatment over 9 days
with mild improvement in seizure frequency and severity. One
year later, NCSE in the same patient was halted by three daily
sessions of ECT. He also reported successful ECT outcome on a 10-
year-old girl with micricephaly and intractable epilepsy despite
AEDs after six sessions of ECT over two weeks. However, in both
cases, AEDs were either held or completely stopped before the ECT
treatment.6 To our knowledge, this is the ﬁrst report for successful
ECT treatment on pediatric NCSE with continuation of AED.
Our patient unfortunately succumbed to unexpected SUDEP
within six months of successful treatment of SE. Even though our
patient died from SUDEP, ECT played an important role in
achieving remission from refractory status epilepticus, allowing
her and her family severalmonths of respite from a severe epileptic
disease. Also unknown is whether an earlier initiation of ECT
therapy might have shortened the duration of SE and whether this
would have improved our patient’s long-term outcome.
ECT may be useful for treatment of pediatric refractory status
epilepticus as demonstrated in our case, even in the absence of a
full ECT-induced generalized seizure and when it may be
considered too risky to fully withdraw antiepileptic drugs. Further
prospective studies of ECT in status epilepticus may be useful in
this condition. The number of treatments needed, as well as the
optimal ECT stimulus characteristics, and the possible role of
earlier initiation of ECT to render better outcomes are among the
questions to be answered.
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